top
Search terms
Results 1 - 10 of 19 - ordered by :
Pages: 1 2
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 08/03/2017 Item size : 424498 bytes
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 09/03/2017
Ehjournal

In his notes he wrote: I found no material disease of the heart, except that the coronary arteries were thickened2 Rudolf Virchow was the first to recognize the inflammatory nature of atherosclerosis ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/03/2015
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Guidelines for the primary prevention of cardiovascular disease (CVD) with statins, including the most recent,1 fail to make optimal ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/11/2015 Item size : 214035 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015
Ehjournal

Based on personal and familial history of premature cardiovascular disease and LDL-cholesterol levels, two validated algorithms for diagnosis of clinical FH were used: the Dutch Lipid Clinic Network ...

European Heart Journal, Nanchen, David, Gencer, Baris, Auer, Reto, Räber, Lorenz, Stefanini, Giulio G., Klingenberg, Roland, Schmied, Christian M., Cornuz, Jacques, Muller, Olivier, Vogt, Pierre, ...

Date : 21/09/2015 Item size : 306214 bytes
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/02/2016 Item size : 183395 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Elevated levels of LDL-cholesterol are determined mainly genetically1 and are the most important risk factor for atherosclerosis in ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/05/2016 Item size : 186101 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Guidelines for the primary prevention of cardiovascular disease (CVD) with statins, including the most recent,1 fail to make optimal ...

European Heart Journal, Lüscher, Thomas F.

Date : 14/11/2015 Item size : 243812 bytes
Ehjournal

An important novel topic in prevention is highlighted by Thomas Münzel and colleagues from the Johannes Gutenberg University in Mainz, Germany in a subsequent two-part clinical review article ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/02/2017 Item size : 207956 bytes